If phase 3 trial results are confirmed, a novel once-weekly pill platform could transform daily medications into weekly ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Xifyrm is indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.

Nicotine pouch maker a step closer to doing so after FDA moves forward modified risk tobacco product applications ...

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

Smokeless nicotine products are benefiting from both longtime cigarette companies and the convenience chains that sell them.